31 Oct, EOD - Indian

SENSEX 79389.06 (-0.69)

Nifty 50 24205.35 (-0.56)

Nifty Bank 51475.35 (-0.64)

Nifty IT 40407.55 (-3.03)

Nifty Midcap 100 56112.85 (-0.40)

Nifty Next 50 69911.75 (-0.51)

Nifty Pharma 22735.55 (1.61)

Nifty Smallcap 100 18602.6 (1.15)

31 Oct, EOD - Global

NIKKEI 225 39081.25 (-0.50)

HANG SENG 20317.33 (-0.31)

S&P 5722.87 (-1.65)

Login/Signup
LOGIN HERE
Cancel

SBI Life Insurance Company Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 540719 | NSE Symbol : SBILIFE | ISIN : INE123W01016 | Industry : Insurance |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
15-Oct-2024 23-Oct-2024 Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve audited financial results for the quarter & half year ended September 30 2024. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated September 26 2024 bearing reference number SBIL/CS/NSE-BSE/2425/147 the trading window is closed from October 01 2024 and will reopen 48 hours after the declaration of audited financial results for the quarter & half year ended September 30 2024. We wish to inform you that the Meeting of the Board of Directors of the Company commenced at 11:40 am and concluded at 2:30 pm on October 23, 2024 which inter-alia approved the Audited Financial Results for the quarter and half year ended September 30, 2024 Read less.. (As Per BSE Announcement Dated on 23.10.2024)
10-Jul-2024 24-Jul-2024 Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve financial results for the quarter ended June 30 2024. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Financial Result for the quarter ended June 2024 Financial results for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 24/07/2024)
10-Apr-2024 26-Apr-2024 Accounts SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve the Audited Financial Result For The Quarter And Year Ended March 31 2024. In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2425/10 dated April 10, 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the meeting of Board of Directors of the Company commenced at 12:00 Noon and concluded at 03:30 P.M. on April 26, 2024 which inter-alia approved the Audited Financial Results for the quarter and financial year ended March 31, 2024. Pursuant to Regulation 33 of the Listing Regulations and other applicable requirements, a copy of the Audited Financial Results for the quarter and financial year ended March 31, 2024 together with the Audit Report in the prescribed format is enclosed. The above information is also made available on the Company's website at www.sbilife.co.in (As Per BSE Announcement dated on 26.04.2024)
08-Apr-2024 08-Apr-2024 Change in Other Executives Appointment of Key Managerial Person
05-Mar-2024 10-Mar-2024 Interim Dividend SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2024 inter alia to consider and approve the payment of Interim Dividend on equity shares of the Company for the Financial Year 2023-24. The record date for determining the shareholders for the payment of Interim Dividend for FY 2023-24 if any declared by the Board of Directors of the Company shall be Saturday March 16 2024. We further inform you that the window for trading in the equity shares of the Company shall remain closed from Tuesday March 5 2024 to Tuesday March 12 2024 (both days inclusive) for all Directors employees of the Company and their immediate relatives in terms of SEBI (Prohibition of Insider Trading) Regulations 2015. We wish to inform that the meeting of Board of Directors of SBI Life Insurance Company Limited commenced at 02:30 PM and concluded at 03:30 PM on Sunday, March 10, 2024 has declared an interim dividend on equity shares of the Company of Rs 2.70/- (Two Rupees and Seventy Paisa only) per equity share with a face value of Rs. 10 each (i.e. 27%) for the Financial Year 2023-24. (As Per BSE Announcement Dated on 10.03.2024)
28-Feb-2024 28-Feb-2024 Change in Directors The following outcome has been approved by the Board of Director 1. Appointment of Mr. Ashwini Kumar Tewari (DIN:08797991) as Nominee Director with effect from January 06, 2024, (the same was intimated to the Stock Exchanges on January 06, 2024) ii. Material Related party transactions for purchase and/ or sale of investments that the Company may enter in FY 2024-25 in the ordinary course of business and at arm's length basis with the related parties as set out in the notice and iii. Material Related Party Transactions with State Bank of India that the Company may enter in FY 2024-25 in the ordinary course of business and at arm's length basis, in compliance with Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
13-Feb-2024 13-Feb-2024 Change in Other Executives Appointment of Company Secretary and Compliance Officer
11-Jan-2024 25-Jan-2024 Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve financial results for the quarter & nine months ended December 31 2023. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated December 29 2023 bearing reference number SBIL/CS/NSE-BSE/2324/193 the trading window will remain closed from January 01 2024 to January 27 2024 (both days inclusive) for declaration of audited financial results for the quarter & nine months ended December 31 2023. Financial Result for the quarter and nine months ended December 2023 (As Per BSE Announcement dated on 25.01.2024)
17-Oct-2023 27-Oct-2023 Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Audited financial results for the quarter & half year ended September 30 2023. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated September 29 2023 bearing reference number SBIL/CS/NSE-BSE/2324/146 the trading window will remain closed from October 01 2023 to October 29 2023 (both days inclusive) for declaration of audited financial results for the quarter & half year ended September 30 2023. In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2324/154 dated October 17, 2023 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the meeting of the Board of Directors of the Company commenced at 12:00 P.M. and concluded at 02:30 P.M. on October 27, 2023 which inter-alia approved the Audited Financial Results for the quarter and half year ended September 30, 2023. Pursuant to Regulation 33 of the Listing Regulations and other applicable requirements, a copy of the Audited Financial Results for the quarter and half year ended September 30, 2023 together with the Audit Report in the prescribed format is enclosed. Further, the trading window to deal in securities of the Company will be re-opened from October 30, 2023, for all the Designated Persons of the Company. In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2324/143 dated September 28, 2023 and pursuant to provisions of Regulation 30 of the SEBI(LODR)Regulations,2015, we wish to inform you that the Board of Directors of the Company in their meeting dated October 27, 2023, have approved and passed a resolution to seek Members'' approval, through Postal Ballot, for the appointment of Mr. Amit Jhingran ( DIN:10255903), as the MD & CEO of the Company. The Notice of Postal Ballot shall be circulated on Monday, October 30, 2023, through electronic mode to all members, whose names appear on the Register of Members maintained by NSDL/CDSL/Registrar and Share Transfer Agent, as the case may be , as on Friday, October 27, 2023(Cut- Off Date).The e-voting period will commence on Tuesday, October 31, 2023 at 09:00 A.M. (IST) and shall end on Wednesday, November 29, 2023 at 05:00 P.M. (IST) (As per BSE Announcement Dated on 27/10/2023)
28-Sep-2023 28-Sep-2023 Change in Directors State Bank of India ('SBI') by way of its communication dated September 26, 2023 has informed the Company that the present MD & CEO of our Company, Mr. Mahesh Kumar Sharma, has been posted as Deputy MD in SBI, Corporate Centre and accordingly will be relieved of his duties as MD & CEO of our Company from the close of business hours on September 30, 2023. Reference to the above and in continuation of our intimation vide ref. no. SBIL/CS/NSE-BSE/2324/83 dated July 25, 2023 and SBIL/CS/NSE-BSE/2324/105 dated August 08, 2023 and pursuant to Regulation 30 of SEBI (LODR) Reg., 2015, we wish to inform you that the Board of Directors, at its Meeting held on September 28, 2023, has approved the appointment of Mr. Amit Jhingran as the MD & CEO of the Company w.e.f. October 01, 2023. The meeting commenced at 04:30 P.M. and concluded at 05:00 P.M.
28-Jul-2023 28-Jul-2023 Change in Directors Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on July 28, 2023 has approved the re-appointment of three Independent Directors. We request you to kindly take the above information on record. We wish to inform you that the Board of Directors in its meeting held on July 28, 2023 has approved the 23rd Annual General Meeting ('AGM') of the Members of the SBI Life Insurance Company Limited to be held on Tuesday, August 29, 2023 at 04:00 PM (IST) through VC/OAVM facility and without the physical presence of the shareholders at a common venue. Other relevant details are being provided in the notice of AGM, which will be issued in due course. (As per BSE Announcement Dated on 28/07/2023)
07-Jul-2023 25-Jul-2023 Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2023 inter alia to consider and approve financial results for the quarter ended June 30 2023. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated June 30 2023 bearing reference number SBIL/CS/NSE-BSE/2324/63 the trading window will remain closed from July 01 2023 to July 27 2023 (both days inclusive) for declaration of financial results for the quarter ended June 30 2023. In continuation to our intimation vide ref. no. SBIL/CS/NSE-BSE/2324/65 dated July 07, 2023 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the meeting of the Board of Directors of the Company commenced at 04:30 P.M. and concluded at 06:30 P.M. on July 25, 2023 which inter-alia approved the Unaudited Financial Results for the quarter ended June 30, 2023. Pursuant to Regulation 33 of the Listing Regulations and other applicable requirements, a copy of the Unaudited Financial Results for the quarter ended June 30, 2023 together with the Limited Review Report in the prescribed format is enclosed. Further, the trading window to deal in securities of the Company will be re-opened from Thursday, July 28, 2023, for all the Designated Persons of the Company. The Board of Directors at its meeting held on July 25, 2023, has approved the appointment of Mr. Amit Jhingran, as Managing Director & CEO and the date of his assuming charge as such will be decided and notified subsequent to receipt of necessary regulatory approval. (As per BSE Announcement Dated on 25/07/2023)
28-Jun-2023 28-Jun-2023 Change in Directors Pursuant to Regulation 30 of LODR, we would like to inform you that the board of directors of the company have approved and passed the following circular resolution today i.e. on Wednesday, June 28, 2023 for seeking members'' approval through postal ballot, an item of ordinary resolution pertaining to re-appointment of Mahesh Kumar Sharma as MD and CEO of the company. The cut off date and details of e-voting are updated in the attachment.
04-May-2023 04-May-2023 Change in Directors The Board of Directors of SBI Life Insurance Company Limited ('the Company') at their meeting held on May 04, 2023 has, inter alia, approved the extension of term of Mr. Mahesh Kumar Sharma as the Managing Director & Chief Executive Officer (MD & CEO) of the Company up to September 30, 2023, subject to Insurance Regulatory and Development Authority of India (IRDAI) and Shareholder's approval. We request to take the above intimation in compliance to the regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 ('Listing Regulations'), as amended and under Section 2(34), 2(51), 196, 197, 203 read with Rule 8 of the Companies (Meetings of Board and its Powers) Rules, 2014. An additional detail as required pursuant to Regulation 30 of the Listing Regulations, as amended is included herewith as Annexure A.
10-Apr-2023 26-Apr-2023 Accounts SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2023 inter alia to consider and approve audited financial result for the quarter and year ended March 31 2023. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated March 31 2023 bearing reference number SBIL/F&A-CS/NSE-BSE/2223/590 the trading window will remain closed from April 01 2023 to April 28 2023 (both days inclusive) for declaration of audited financial results for the quarter and financial year ended March 31 2023. In continuation of our intimation vide ref. no. SBIL/F&A-CS/NSE-BSE/2324/8 dated April 10, 2023 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the meeting of the Board of Directors of the Company commenced at 04:30 P.M. and concluded at 07:00 P.M. on April 26, 2023 which inter-alia approved the Audited Financial Results for the quarter and year ended March 31, 2023. Pursuant to Regulation 33 of Listing Regulations and other applicable requirements, a copy of the Audited Financial Results for the quarter and year ended March 31, 2023 together with the Independent Auditors Report in the prescribed format is enclosed. A copy of press release being issue in this connection is also enclosed. The above information is also made available on the Company's website at www.sbilife.co.in (As per BSE Announcement Dated on 26/04/2023)
1 2 3